Menu Close
logo logo
Home icon-svg
Expertise icon-svg
Territories icon-svg
Services icon-svg
Compliance icon-svg
Alliance Members
CTS Israel EffRx Pharmaceuticals Switzerland Medis Central and Eastern Europe OrphanDC Latin America Orpharm Russia and CIS region Path Pharma Greece, Cyprus, Malta RareStone Group Greater China Vector Pharma Middle East, North Africa and Turkey
logo logo

News

Improving PKU Management

Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East

Jun 2023

Latest News

Jun 2023 Improving PKU Management

Relief Therapeutics and World Orphan Drug Alliance Announce an Exclusive, Long-Term, Distribution Agreement to Introduce PKU GOLIKE® in the Middle East

Companies join forces to introduce PKU GOLIKE Plus® 3-16, a breakthrough treatment for phenylketonuria (PKU), in the Middle East.

Read more Sep 2023 NEW WODA MEMBER FOR AUSTRALIA, NEW ZEALAND AND SOUTHEAST ASIA

World Orphan Drug Alliance Welcomes Specialised Therapeutics

Specialised Therapeutics to represent WODA in Australia, New Zealand and across Southeast Asia (ANZSEA)

Read more
logo-footer logo-footer
Expertise Territories Services Compliance
Alliance Members Contact for Partners Contact for Media Linkedin